SILO
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Silo Pharma will showcase its patented nose-to-brain drug delivery technology for PTSD at the 2026 Nasal Innovation ForumSep 10, 2026
- Silo Pharma files provisional patent for ibogaine-based therapy targeting traumatic brain injuryMay 7, 2026
- Silo Pharma positioned its PTSD treatment program to advance after the executive order supporting psychedelic researchApr 20, 2026
- Silo Pharma received European patent allowance for PTSD prevention therapyApr 7, 2026
- Silo Pharma executes letter of intent with Allucent for SPC-15 Phase 1 developmentDec 30, 2025